Alyglo
Administration: IVIG
Concentration: 10% (100 mg/mL)
Approved for: Ages 17+
Report side effects/adverse reactions at medicalinfo@gcbiopharmausa.com or 1-833-426-6426.
Young adult roundtable: College, mental health, and PI
December 18, 2023
Listen to podcast
Law student with PI lends talent to IDF
December 14, 2023
Read article
ADA-SCID Gene Therapy Update with Dr. Donald Kohn
December 11, 2023
Listen to podcast
Fund your research
IDF’s Research Grant Program supports patient-centered biomedical research focused on improving the treatment, health, disease management, or diagnosis of people with PI.
Discovery of new PI shows value of grants for exploratory research
December 08, 2023
Read article
Autoimmunity in PI causes blood disorders, GI issues, lung problems
December 06, 2023
Read article
FDA must consider patient access in seeking test regulations
December 05, 2023
View PDF
Undiagnosed (feat. The Autism Dad): Father and Son
December 05, 2023
Listen to podcast
All Copays Count Coalition disappointed in decision to appeal court ruling
December 05, 2023
View PDF
